{"id":2615,"date":"2026-05-13T05:07:32","date_gmt":"2026-05-13T05:07:32","guid":{"rendered":"https:\/\/education.mirrorplasticsurgery.com\/uncategorized\/peptide-injections-for-hair-growth\/"},"modified":"2026-09-10T05:24:03","modified_gmt":"2026-09-10T05:24:03","slug":"peptide-injections-for-hair-growth","status":"publish","type":"post","link":"https:\/\/www.mirrorplasticsurgery.com\/education\/peptides\/peptide-injections-for-hair-growth","title":{"rendered":"Peptide Injections for Hair Growth: A Surgeon&#8217;s Guide"},"content":{"rendered":"<p><em>Written by: Dr. Akash Chandawarkar, Board Certified Plastic Surgeon, Mirror Plastic Surgery | Last updated: September 9, 2026<\/em><\/p>\n<h2 id=\"key-takeaways\">Key Takeaways<\/h2>\n<ul>\n<li>Peptide injections for hair growth are an off-label treatment, and no injectable peptide is FDA-approved for this purpose.<\/li>\n<li>GHK-Cu has the strongest mechanistic and clinical evidence among peptides studied for hair, and it works as an adjunct rather than a standalone cure.<\/li>\n<li>Visible results usually require 3\u20136 months of consistent treatment, with reduced shedding often appearing first within 2\u20134 weeks.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup><\/li>\n<li>The greatest danger is unregulated sourcing and lack of medical oversight, with roughly one-third of tested products failing quality checks.<\/li>\n<li>Peptides complement proven first-line treatments like minoxidil and finasteride; schedule a consultation to explore whether peptide therapy fits your specific hair loss pattern.<\/li>\n<\/ul>\n<h2>How Peptide Injections Support Hair Growth<\/h2>\n<p>Peptides are short chains of amino acids that act as signaling molecules and tell cells to perform specific biological functions. In hair restoration, they target the follicle microenvironment, reduce inflammation, stimulate growth-phase cycling, and improve blood supply to the scalp.<\/p>\n<p>Clinicians use two main delivery routes. Scalp mesotherapy uses localized micro-injections across thinning areas and delivers peptides directly to the follicular layer. Subcutaneous injection delivers peptides systemically and relies on circulation to reach scalp tissue. Each route behaves differently in the body. <a href=\"https:\/\/peptidesexplorer.com\/blog\/ghk-cu-hair-growth\" target=\"_blank\" rel=\"noindex nofollow\">Injectable GHK-Cu reaches follicle-depth tissue at 10 to 20 times the concentration of topical serums<\/a>, while topical application with microneedling still has the most coherent human evidence base for hair.<\/p>\n<p><strong>Peptide injections for hair growth are an off-label treatment, and no injectable peptide is FDA-approved for this indication.<\/strong> Regulatory status continues to evolve. <a href=\"https:\/\/cnn.com\/2026\/07\/22\/health\/peptides-fda-compounding-pharmacies-meeting-wellness\" target=\"_blank\" rel=\"noindex nofollow\">In July 2026, the FDA&#8217;s Pharmacy Compounding Advisory Committee voted to recommend adding several peptides including BPC-157 and TB-500 to the 503A Bulks List<\/a>, which would create a lawful compounding pathway. These recommendations remain advisory, and none of the peptides under review are FDA-approved drugs.<\/p>\n<h2>Injectable Peptides Commonly Discussed for Hair Growth<\/h2>\n<h3>GHK-Cu (Copper Peptide): The Most Studied Option<\/h3>\n<p>GHK-Cu is a naturally occurring copper-binding tripeptide first isolated from human plasma in 1973. <a href=\"https:\/\/gethealthspan.com\/research\/article\/ghk-cu-hair-growth-evidence-review\" target=\"_blank\" rel=\"noindex nofollow\">Circulating GHK-Cu levels decline approximately 60% between a person&#8217;s 20s and 60s<\/a>, from roughly 200 ng\/mL to 80 ng\/mL, and this drop correlates with slower wound healing and hair thinning.<\/p>\n<p>Its mechanisms are highly relevant for hair loss. <a href=\"https:\/\/gethealthspan.com\/research\/article\/ghk-cu-hair-growth-evidence-review\" target=\"_blank\" rel=\"noindex nofollow\">A 2018 study in Scientific Reports confirmed that GHK-Cu activates Wnt\/\u03b2-catenin signaling in human dermal papilla cells<\/a>, which orchestrate the hair growth cycle. It also <a href=\"https:\/\/gethealthspan.com\/research\/article\/ghk-cu-hair-growth-evidence-review\" target=\"_blank\" rel=\"noindex nofollow\">inhibits TGF-\u03b21, a cytokine that promotes fibrosis and chokes follicle function<\/a>, and <a href=\"https:\/\/gethealthspan.com\/research\/article\/ghk-cu-hair-growth-evidence-review\" target=\"_blank\" rel=\"noindex nofollow\">reduces androgen receptor gene expression in follicular cells<\/a>, which suggests a complementary role alongside direct DHT blockade.<\/p>\n<p>The clinical evidence remains promising yet limited. <a href=\"https:\/\/weightlossrankings.org\/research\/ghk-cu-skin-hair-evidence\" target=\"_blank\" rel=\"noindex nofollow\">As of mid-2026, no large, independent, multi-center randomized controlled trial of GHK-Cu alone for androgenetic alopecia has been published<\/a>. The best human data comes from small trials and older studies, including a <a href=\"https:\/\/gethealthspan.com\/research\/article\/ghk-cu-hair-growth-evidence-review\" target=\"_blank\" rel=\"noindex nofollow\">1993 double-blind trial showing hair density improvements comparable to 5% minoxidil over 6 months<\/a>, but sample sizes were small and never replicated at scale. GHK-Cu does not block DHT, so it does not address the hormonal root cause of androgenetic alopecia. It works best as an adjunct to established therapies rather than a replacement.<\/p>\n<h3>BPC-157: The Tissue Repair Peptide<\/h3>\n<p>BPC-157 is well-studied for gut healing and musculoskeletal repair, yet its use for hair growth lacks scientific support. <a href=\"https:\/\/anagen.xyz\/treatment-science\/bpc-157\" target=\"_blank\" rel=\"noindex nofollow\">As of July 2026, PubMed indexes 222 BPC-157 papers, and none of them study hair, alopecia, hair follicles, dermal papilla, or scalp<\/a>. A widely repeated claim about a clinical study of 30 patients with androgenetic alopecia does not appear in any database.<\/p>\n<p><a href=\"https:\/\/anagen.xyz\/treatment-science\/bpc-157\" target=\"_blank\" rel=\"noindex nofollow\">A 2001 mouse burn study that reported &#8220;preserved follicles&#8221; is routinely misread<\/a>. In that paper, follicle counts measured burn damage depth rather than hair growth. BPC-157&#8217;s demonstrated mechanisms do not address DHT, follicle miniaturization, or Wnt\/\u03b2-catenin signaling. For hair specifically, the evidence remains theoretical.<\/p>\n<h3>TB-500 (Thymosin Beta-4): The Wound Healing Peptide<\/h3>\n<p>TB-500 is a synthetic fragment of Thymosin Beta-4 with documented roles in cell migration and angiogenesis. <a href=\"https:\/\/realpeptides.co\/tb-4-hair-growth-clinical-evidence-2026-protocols\" target=\"_blank\" rel=\"noindex nofollow\">Research published in the Journal of Investigative Dermatology found that Thymosin Beta-4 directly activates hair follicle stem cells via the Wnt\/\u03b2-catenin signaling pathway<\/a>. <a href=\"https:\/\/realpeptides.co\/tb-4-hair-growth-clinical-evidence-2026-protocols\" target=\"_blank\" rel=\"noindex nofollow\">A 2020 case series in the International Journal of Trichology documented a mean hair count increase of 18 hairs per cm\u00b2 at 24 weeks in TB-4-treated patients versus 3 hairs per cm\u00b2 in placebo<\/a>.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup><\/p>\n<p><a href=\"https:\/\/peptidings.com\/guides\/hair-loss-peptides\" target=\"_blank\" rel=\"noindex nofollow\">No controlled human trials exist specifically targeting hair loss<\/a>, and TB-500 is prohibited by the World Anti-Doping Agency. The mechanism appears plausible, while the human evidence for hair remains anecdotal.<\/p>\n<h3>Growth Hormone Secretagogues (Sermorelin, Ipamorelin)<\/h3>\n<p>Sermorelin and Ipamorelin stimulate natural growth hormone production and raise IGF-1 levels. <a href=\"https:\/\/rxpepsdirect.com\/learn\/peptides-for-hair-growth-comparison\" target=\"_blank\" rel=\"noindex nofollow\">Hair is a secondary downstream benefit of elevated IGF-1, not the primary target<\/a>, and no clinical trial evidence supports these peptides as hair loss treatments. They do not function as targeted hair therapies.<\/p>\n<h3>Best Injectable Peptide Role in a Hair Growth Plan<\/h3>\n<p>Based on current evidence, GHK-Cu is the most studied and mechanistically relevant peptide for hair, yet no injectable peptide has proven efficacy comparable to finasteride or minoxidil. That is why GHK-Cu&#8217;s realistic role is as a potential adjunct within a physician-supervised, multi-modal protocol rather than a standalone solution.<\/p>\n<h2>What Results You Can Realistically Expect<\/h2>\n<p>Hair biology moves slowly, so timelines must stay grounded in physiology. <a href=\"https:\/\/peptidesexplorer.com\/blog\/ghk-cu-hair-growth\" target=\"_blank\" rel=\"noindex nofollow\">Reduced shedding typically appears within 2\u20134 weeks, fine vellus hairs at 6\u201312 weeks, and measurable density improvement requires 16\u201324 weeks of consistent treatment<\/a>.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup><\/p>\n<p>For suitable candidates, realistic outcomes tend to appear in stages.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup> Reduced daily shedding often comes first, followed by thicker, stronger existing hairs and healthier scalp tissue with less perifollicular inflammation.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup> Modest density improvement may occur in areas where follicles remain miniaturized but still active.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup><\/p>\n<p><strong>Peptides cannot revive completely scarred or fibrosed follicles.<\/strong> <a href=\"https:\/\/realpeptides.co\/tb-4-hair-growth-clinical-evidence-2026-protocols\" target=\"_blank\" rel=\"noindex nofollow\">Stopping treatment typically leads to a gradual return to baseline over 6\u201312 months<\/a>.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup><\/p>\n<h2>Peptide Injections for Hair Growth: Side Effects and Risks<\/h2>\n<p>Most side effects of peptide injections are mild and local. Patients may notice injection site pain, redness, swelling, or transient shedding in the early weeks of treatment. <a href=\"https:\/\/realpeptides.co\/tb-4-hair-growth-clinical-evidence-2026-protocols\" target=\"_blank\" rel=\"noindex nofollow\">Localized injection site reactions occur in approximately 15\u201320% of patients and typically resolve within 24\u201348 hours<\/a>.<\/p>\n<p><strong>The real danger is unregulated sourcing, not the peptides themselves.<\/strong> <a href=\"https:\/\/theguardian.com\/science\/2026\/apr\/06\/labs-testing-thousands-of-unregulated-substances-amid-peptide-craze\" target=\"_blank\" rel=\"noindex nofollow\">Independent testing laboratories have reported that roughly one-third of the thousands of peptide products analyzed failed basic quality checks<\/a>, including wrong identity, purity below threshold, and inaccurate dosing. <a href=\"https:\/\/rethinkpeptides.com\/articles\/online-peptide-vendors-legal-liability-and-consumer-risk\" target=\"_blank\" rel=\"noindex nofollow\">Independent testing services report that 15\u201320% of vendor-supplied certificates of analysis contain discrepancies when independently verified<\/a>, such as overstated purity and incorrect peptide identity.<\/p>\n<p>Self-administration multiplies these risks. <a href=\"https:\/\/allmeds.ai\/peptides\/peptide-injections-side-effects\" target=\"_blank\" rel=\"noindex nofollow\">Self-injection with research-grade or gray-market peptides introduces dosing errors, reconstitution errors, needle misuse, and lack of sterile technique<\/a>. These problems do not occur in a properly supervised clinical setting.<\/p>\n<p>Key contraindications include active cancer because of theoretical pro-angiogenic concerns, pregnancy, and Wilson&#8217;s disease for GHK-Cu specifically. Medical supervision enables proper screening, accurate dosing, quality sourcing from compounding pharmacies with batch testing, and ongoing monitoring. Given this risk profile, understanding side effects and sourcing is as important as understanding potential benefits.<\/p>\n<p><a href=\"https:\/\/www.mirrorplasticsurgery.com\/consultation\" target=\"_blank\">Schedule a consultation with Mirror Plastic Surgery to explore if peptide therapy is right for you. Dr. Akash reviews every patient&#8217;s labs and medical history before designing any protocol.<\/a><\/p>\n<figure style=\"text-align: center\"><a href=\"https:\/\/www.mirrorplasticsurgery.com\/about-us\/dr.-akash-chandawarkar\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/cdn.aigrowthmarketer.co\/1788902121774-3fcf2fc7e0ba.webp\" alt=\"Dr. Akash, Board-Certified Plastic Surgeon\" style=\"max-height: 500px\" loading=\"lazy\"><\/a><figcaption><em>Dr. Akash, Board-Certified Plastic Surgeon<\/em><\/figcaption><\/figure>\n<h2>How Peptides Compare to PRP and Other Hair Loss Treatments<\/h2>\n<p>Peptides sit alongside other adjunctive options and do not replace first-line therapies. Minoxidil and finasteride remain the only FDA-approved pharmacological treatments for androgenetic alopecia and have decades of large randomized controlled trial data. <a href=\"https:\/\/rxpepsdirect.com\/learn\/peptides-for-hair-growth-comparison\" target=\"_blank\" rel=\"noindex nofollow\">A 48-week randomized, double-blind, placebo-controlled trial in 393 men found that 5% topical minoxidil produced about 45% more hair regrowth than the 2% solution<\/a>.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup> Finasteride directly addresses the hormonal root cause of male pattern baldness by inhibiting 5-alpha-reductase and lowering DHT, and no peptide affects this pathway.<\/p>\n<p>PRP and peptides occupy a similar evidence tier. <a href=\"https:\/\/rxpepsdirect.com\/learn\/peptides-for-hair-growth-comparison\" target=\"_blank\" rel=\"noindex nofollow\">A systematic review and meta-analysis of 27 controlled trials found that PRP increased hair density by a mean of 25.6 hairs\/cm\u00b2 compared to saline<\/a>.<sup data-disclaimer-id=\"6\" data-disclaimer-index=\"1\">1<\/sup> yet the authors rated the evidence as low quality because of inconsistency and risk of bias. Neither PRP nor peptides address DHT, so neither should serve as a standalone solution for androgen-driven pattern baldness.<\/p>\n<p>GHK-Cu&#8217;s non-hormonal mechanism makes it particularly relevant for women who cannot take finasteride. For men and women who have had partial responses to conventional therapy, peptides offer complementary pathways such as Wnt activation, TGF-\u03b2 suppression, and angiogenesis that minoxidil and finasteride do not cover. Hair transplantation remains the surgical gold standard for advanced loss when follicles are no longer viable.<\/p>\n<h2>What a Proper Peptide Treatment Protocol Includes<\/h2>\n<p>A responsible peptide protocol starts with a thorough evaluation, not the first injection. At Mirror Plastic Surgery, Dr. Akash conducts a comprehensive consultation that includes a full medical history review and, when indicated, lab panels covering thyroid function, ferritin, hormone levels, and other contributors. <a href=\"https:\/\/juliandouwes.com\/peptides\/hair-restoration\/hair-loss\" target=\"_blank\" rel=\"noindex nofollow\">Nutritional deficiencies, particularly ferritin below 50 ng\/mL, are among the most commonly missed and easily correctable causes of hair loss<\/a>. Addressing these issues before peptide therapy improves outcomes.<\/p>\n<p>For GHK-Cu, <a href=\"https:\/\/peptidedeck.com\/blog\/ghk-cu-peptide-benefits-dosage-guide\" target=\"_blank\" rel=\"noindex nofollow\">a typical injectable protocol involves 1\u20133 mg subcutaneously 2\u20134 times weekly, with an 8\u201312 week on-cycle followed by a 4-week off-cycle<\/a>. Many patients combine this with scalp microneedling to enhance delivery. Protocols must be tailored to the individual. The right approach depends on the severity of loss, underlying cause, and concurrent treatments rather than a one-size-fits-all dose.<\/p>\n<p>At Mirror Plastic Surgery, every protocol is designed around each patient&#8217;s labs and physiology and remains medically supervised throughout. The team sources peptides from reputable providers with batch-specific testing. Dr. Akash is available via text or scheduled telemedicine for ongoing support, which creates the continuity that makes peptide therapy safer and more effective than self-directed protocols.<\/p>\n<h2>Questions to Ask Before Getting Peptide Injections<\/h2>\n<p>Clear questions help you evaluate whether a provider offers safe, evidence-informed care. Before committing to any peptide injection protocol for hair growth, ask every prospective provider the following:<\/p>\n<ul>\n<li>What peptides do you recommend for my specific hair loss pattern, and why?<\/li>\n<li>Are you board-certified, and how much experience do you have with peptide therapy?<\/li>\n<li>Where do you source your peptides, and can you provide batch-specific certificates of analysis?<\/li>\n<li>What are the potential side effects, and how do you manage them?<\/li>\n<li>What is the realistic timeline for results, and what is the maintenance protocol?<\/li>\n<li>What lab work will you review before designing my protocol?<\/li>\n<\/ul>\n<p>A qualified provider answers these questions clearly and in detail. <a href=\"https:\/\/rethinkpeptides.com\/articles\/online-peptide-vendors-legal-liability-and-consumer-risk\" target=\"_blank\" rel=\"noindex nofollow\">Red flags include providers who prescribe injectable peptides without discussing evidence limitations or who source from research vendors instead of licensed compounding facilities<\/a>.<\/p>\n<h2>Making an Informed Decision<\/h2>\n<p>Peptide injections for hair growth represent a promising yet still experimental adjunct to established hair loss care. The evidence is strongest for GHK-Cu, which has plausible and well-characterized mechanisms and the most human data of any peptide in this space. BPC-157 has no published hair studies. TB-500 has preclinical and limited human signals but no controlled hair trials. None of these peptides replace finasteride or minoxidil for androgen-driven pattern baldness.<\/p>\n<p>Results take months, and maintenance is required to sustain them. Risks of unsupervised use, including contaminated products, dosing errors, and absent screening, are real and documented. The difference between a safe, informed trial and a costly gamble is a board-certified physician who understands both the science and your individual physiology.<\/p>\n<p><a href=\"https:\/\/www.mirrorplasticsurgery.com\/consultation\" target=\"_blank\">Book a consultation with Dr. Akash Chandawarkar to get an honest, evidence-based assessment tailored to your labs and goals.<\/a><\/p>\n<p><em>Peptide injections for hair growth are considered off-label and are not FDA-approved. Results vary. Always consult a qualified physician before starting any peptide therapy.<\/em><\/p>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Are Peptide Injections for Hair Growth Safe?<\/h3>\n<p>Safety depends on the specific peptide and the quality of medical oversight. GHK-Cu has a notably clean safety profile in existing research, with primary risks including mild scalp irritation, theoretical copper overload in individuals with Wilson&#8217;s disease, and contamination risk from improperly sourced products. BPC-157 and TB-500 carry more uncertainty because human safety data is extremely limited, total human exposure across all published trials is small, and long-term effects remain unknown.<\/p>\n<p>The most significant safety risks in practice come from unregulated online products and from self-administration without proper sterile technique or dosing guidance. As noted earlier, a significant proportion of online products fail quality checks. Medical supervision that includes pre-treatment screening, quality-controlled sourcing, and ongoing monitoring separates a responsible protocol from a dangerous one.<\/p>\n<h3>How Long Does It Take to See Results from Peptide Injections for Hair?<\/h3>\n<p>Hair biology operates on a slow cycle, so expectations should match that pace. As discussed earlier, results follow a predictable sequence: reduced shedding usually appears first, then fine vellus hairs, and density gains take several months to emerge. Stopping treatment generally reverses gains over time, so maintenance remains necessary for sustained results.<\/p>\n<h3>Can Peptide Injections Replace Minoxidil or Finasteride?<\/h3>\n<p>Peptide injections do not replace minoxidil or finasteride. Minoxidil and finasteride are the only FDA-approved pharmacological treatments for androgenetic alopecia and have decades of large randomized controlled trial data supporting their use. Finasteride directly addresses the hormonal root cause of male pattern baldness by reducing DHT, and no peptide replicates this mechanism. Minoxidil prolongs the hair growth phase and improves follicular blood supply.<\/p>\n<p>Peptides like GHK-Cu work through complementary pathways such as Wnt\/\u03b2-catenin activation, TGF-\u03b2 suppression, and angiogenesis. For most patients, the most defensible approach is a multi-modal protocol that uses proven treatments as the foundation and adds peptides as an adjunct to address additional biological pathways. For women who cannot take finasteride, non-hormonal peptide options like GHK-Cu become more relevant within a supervised protocol.<\/p>\n<h3>What Is the Difference Between Topical and Injectable GHK-Cu for Hair Growth?<\/h3>\n<p>The main difference lies in delivery depth and concentration at the follicle. The hair follicle bulb sits roughly 3\u20134 mm below the skin surface, and topical GHK-Cu has limited passive penetration through intact skin because of its molecular charge at skin-surface pH. Microneedling dramatically improves topical absorption, by up to 10-fold, and makes it the most evidence-aligned delivery method for topical GHK-Cu.<\/p>\n<p>Injectable GHK-Cu reaches follicle-depth tissue at significantly higher concentrations than topical serums. However, existing clinical hair trials used topical formulations, and no strong comparative study shows that injected GHK-Cu produces better hair outcomes than well-formulated topical application with microneedling. Injectable GHK-Cu also faces stricter regulatory considerations. A physician can assess which delivery route fits your severity of loss, history, and goals.<\/p>\n<h3>Why Should I Choose a Physician-Led Practice Over an Online Peptide Vendor?<\/h3>\n<p>Physician-led care reduces the major risks associated with peptides. Independent testing has found that a significant proportion of online peptide products fail quality checks, including wrong peptide identity, inaccurate dosing, and purity below stated levels. Without a physician, you lose pre-treatment screening for contraindications, lab work to rule out correctable causes of hair loss like thyroid dysfunction or iron deficiency, guidance on correct dosing and cycling, and monitoring for adverse effects.<\/p>\n<p>A physician-led practice sources peptides from licensed compounding facilities with batch-specific certificates of analysis, designs protocols around your individual labs and physiology, and provides ongoing support throughout treatment. At Mirror Plastic Surgery, Dr. Akash Chandawarkar personally leads every peptide protocol and provides the medical oversight that turns a high-risk experiment into a structured, informed trial.<\/p>\n<hr data-disclaimer-divider=\"true\">\n<div data-disclaimer-footer=\"true\">\n<p data-disclaimer-id=\"6\" data-disclaimer-type=\"content_based\"><sup data-disclaimer-index=\"1\">1<\/sup> Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.<\/p>\n<p data-disclaimer-id=\"5\" data-disclaimer-type=\"fixed\">Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.<\/p>\n<\/div>\n<section data-read-next=\"true\">\n<h2>Read Next<\/h2>\n<ul>\n<li><a href=\"https:\/\/education.mirrorplasticsurgery.com\/peptides\/peptides-for-hair-growth-dermatologists\" target=\"_blank\">Peptides for Hair Growth: What Dermatologists Recommend<\/a><\/li>\n<li><a href=\"https:\/\/education.mirrorplasticsurgery.com\/peptides\/do-peptides-work-hair-growth\" target=\"_blank\">How Peptides Work for Hair Growth: GHK-Cu Clinical Guide<\/a><\/li>\n<li><a href=\"https:\/\/education.mirrorplasticsurgery.com\/peptides\/best-hair-growth-peptides-2026\" target=\"_blank\">Best Hair Growth Peptides: A Physician&#8217;s 2026 Ranking<\/a><\/li>\n<li><a href=\"https:\/\/education.mirrorplasticsurgery.com\/peptides\/peptides-for-hair-regrowth-2026\" target=\"_blank\">Peptides for Hair Regrowth: Evidence, Types &amp; Protocols<\/a><\/li>\n<li><a href=\"https:\/\/education.mirrorplasticsurgery.com\/peptides\/peptide-stacks-for-hair-growth\" target=\"_blank\">Peptide Stacks for Hair Growth: GHK-Cu, BPC-157 &amp; TB-500<\/a><\/li>\n<\/ul>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Explore peptide injections for hair growth with expert insight from Mirror Plastic Surgery. Learn what works, what&#8217;s safe, and how to get started.<\/p>\n","protected":false},"author":21,"featured_media":2614,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-2615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-peptides"],"_links":{"self":[{"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/posts\/2615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/comments?post=2615"}],"version-history":[{"count":2,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/posts\/2615\/revisions"}],"predecessor-version":[{"id":5292,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/posts\/2615\/revisions\/5292"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/media\/2614"}],"wp:attachment":[{"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/media?parent=2615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/categories?post=2615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mirrorplasticsurgery.com\/education\/wp-json\/wp\/v2\/tags?post=2615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}